Trademark: 88620374
Word
TULVEGIO RIVOCERANIB
Status
Pending
Status Code
734
Status Date
Tuesday, February 13, 2024
Serial Number
88620374
Mark Type
3000
Filing Date
Tuesday, September 17, 2019
Published for Opposition
Tuesday, June 22, 2021

Trademark Owner History
Elevar Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
42 Development of therapeutics for the treatment of cancer containing rivoceranib
The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
Color is not claimed as a feature of the mark.
The wording "TULVEGIO RIVOCERANIB" has no meaning in a foreign language.
"RIVOCERANIB"

Trademark Events
Feb 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 13, 2024
Sou Extension 5 Granted
Feb 13, 2024
Sou Extension 5 Filed
Feb 13, 2024
Sou Teas Extension Received
Aug 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2023
Sou Extension 4 Granted
Aug 15, 2023
Sou Extension 4 Filed
Aug 21, 2023
Case Assigned To Intent To Use Paralegal
Aug 15, 2023
Sou Teas Extension Received
Feb 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2023
Sou Extension 3 Granted
Feb 15, 2023
Sou Extension 3 Filed
Feb 15, 2023
Sou Teas Extension Received
Aug 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2022
Sou Extension 2 Granted
Aug 1, 2022
Sou Extension 2 Filed
Aug 1, 2022
Sou Teas Extension Received
Jun 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 8, 2022
Teas Change Of Correspondence Received
Jun 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 8, 2022
Teas Change Of Owner Address Received
Feb 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 17, 2022
Sou Extension 1 Granted
Feb 17, 2022
Sou Extension 1 Filed
Feb 17, 2022
Sou Teas Extension Received
Aug 17, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 22, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 22, 2021
Published For Opposition
Jun 2, 2021
Notification Of Notice Of Publication E-Mailed
May 19, 2021
Approved For Pub - Principal Register
May 19, 2021
Examiner's Amendment Entered
May 19, 2021
Notification Of Examiners Amendment E-Mailed
May 19, 2021
Examiners Amendment E-Mailed
May 19, 2021
Examiners Amendment -Written
May 19, 2021
Teas/Email Correspondence Entered
May 19, 2021
Correspondence Received In Law Office
May 17, 2021
Assigned To Lie
Feb 9, 2021
Teas Response To Office Action Received
Jan 8, 2021
Notification Of Non-Final Action E-Mailed
Jan 8, 2021
Non-Final Action E-Mailed
Jan 8, 2021
Non-Final Action Written
Jan 4, 2021
Previous Allowance Count Withdrawn
Dec 29, 2020
Withdrawn From Pub - Og Review Query
Dec 15, 2020
Approved For Pub - Principal Register
Dec 14, 2020
Teas/Email Correspondence Entered
Dec 14, 2020
Correspondence Received In Law Office
Dec 14, 2020
Teas Response To Office Action Received
Jun 12, 2020
Notification Of Non-Final Action E-Mailed
Jun 12, 2020
Non-Final Action E-Mailed
Jun 12, 2020
Non-Final Action Written
May 18, 2020
Teas/Email Correspondence Entered
May 16, 2020
Correspondence Received In Law Office
May 16, 2020
Teas Response To Office Action Received
Nov 16, 2019
Notification Of Non-Final Action E-Mailed
Nov 16, 2019
Non-Final Action E-Mailed
Nov 16, 2019
Non-Final Action Written
Nov 12, 2019
Assigned To Examiner
Sep 25, 2019
Notice Of Design Search Code E-Mailed
Sep 24, 2019
New Application Office Supplied Data Entered
Sep 20, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24